Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2185553Generated: October 31, 2026

4-(N-((4-Nitrobenzyl)oxycarbonyl)-N-(prop-1-yl)amino)-piperidine trifluoroacetate → 2-(R)-(3-(S)-(4-(N-((4-Nitrobenzyl)oxycarbonyl)-N-(prop-1-yl)amino)-piperidin-1-yl)methyl-4-(S)-phenyl-pyrrolidin-1-yl)-2-(cyclohexyl)acetic acid

https://huagongshe.com/reaction/2185553

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(N-((4-Nitrobenzyl)oxycarbonyl)-N-(prop-1-yl)amino)-piperidine trifluoroacetateHCID 22458250—
Reactantalpha-(R)-(3-(R)-formyl-4-(S)-phenylpyrrolidin-1-yl)-cyclohexaneacetic acid 4-methoxybenzyl esterHCID 53654320—
Product2-(R)-(3-(S)-(4-(N-((4-Nitrobenzyl)oxycarbonyl)-N-(prop-1-yl)amino)-piperidin-1-yl)methyl-4-(S)-phenyl-pyrrolidin-1-yl)-2-(cyclohexyl)acetic acidHCID 2134109189%

Reaction Steps

The title compound was prepared from 4-(N-((4-nitrobenzyl)oxycarbonyl)-N-(prop-1-yl)amino)-piperidine trifluoroacetate (21 mg, 0.048 mmol, from Step A) and 2-(R)-(3-(R)-formyl-4-(S)-phenyl-pyrrolidin-1-yl)-2-(cyclohexyl)acetic acid, 4-(methoxy)benzyl ester (14 mg, 0.028 mmol, Aldehyde 5) according to the method described in Example 1, Step C to give 15 mg (89%) of the title compound. ESI-MS: 621.4 (M+H); HPLC A: 2.61 min.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06399619B1
Source datasetuspto-grants-2002_06
ORD IDord-e540758e121c42e396eac3dc0fca6b5c
Source noteuspto-grants-2002_06